In our results, we demonstrated that OLA1 is a positive regulator of the EMT process regardless in the paclitaxel acquired resistance (MCF-7-PTR) cell or endogenous drug resistance cell (MDA-MB-231) in breast cancer. The gene discussed is OLA1; the disease is breast cancer.